Evaluation and comparison of three different anti-hepatitis C virus antibody tests based on chemiluminescence and enzyme-linked immunosorbent assay methods used in the diagnosis of hepatitis C infections in Turkey

Journal of International Medical Research

Volumn 37, Issue 5, 2009, Pages 1420-1429

  Kesli, Recep ^a   Ozdemir, M ^b   Kurtoglu, M G ^a   Baykan, M ^b   Baysal, B ^b  

^a Meram Yeniyol ^*  (Turkey)

^b SELCUK UNIVERSITY   (Turkey)

Author keywords

Anti HCV tests; False positive results; HCV RNA assay; Hepatitis C virus (HCV) infections; Recombinant immunoblot assay (RIBA)

Indexed keywords

NONSTRUCTURAL PROTEIN 3; NONSTRUCTURAL PROTEIN 4; RECOMBINANT ANTIGEN; RECOMBINANT ANTIGEN C22 3; RECOMBINANT ANTIGEN C33C; RECOMBINANT ANTIGEN HCR43; RECOMBINANT ANTIGEN NS5; RECOMBINANT PROTEIN; RECOMBINANT PROTEIN C100 3; RECOMBINANT PROTEIN C200; SYNTHETIC PEPTIDE; SYNTHETIC PEPTIDE 5-1-1; SYNTHETIC PEPTIDE C100; SYNTHETIC PEPTIDE C22; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS RNA;

ADULT; AGED; ANALYZER; ARTICLE; BLOOD SAMPLING; CHEMOLUMINESCENCE; CONTROLLED STUDY; DIAGNOSTIC KIT; ELECTROCHEMILUMINESCENCE IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE RESULT; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOASSAY; IMMUNOBLOTTING; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; RECOMBINANT STRIP IMMUNOBLOT ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCREENING TEST;

EID: 70449625552     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000903700516     Document Type: Article

References (31)

1. Feinstone SM, Kapikian AZ, Purcell RH, et al: Transfusion-associated hepatitis not due to viral hepatitis type A or B. N Engl J Med 1975; 292: 776-1770
2. Lemon SM, Walker C, Alter MJ, et al: Hepatitis C virus. In: Fields Virology, 5th edn, Vol 1 (Knipe DM, Howley PM, eds). Philadelphia: Wolters Kluwer - Lippincott Williams & Wilkins, 2007; pp 1253 - 1304.
3. Choo Q-L, Richman KH, Han JH, et al: Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci USA 1991; 88: 2451-2455.
4. Kuo G, Choo QL, ALter HJ, et al: An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989; 244: 362-364. (Pubitemid 19117878)
5. Feucht HH, Zöllner B, Polywka S, et al: Study on reliability of commercially available hepatitis C virus antibody tests. J Clin Microbiol 1995, 33: 620-624.
6. Thomas DL, Ray SC, Lemon SM: Hepatitis C. In: Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases, 6th edn (Mandell GL, Bennett JE, Dolin R, eds). Philadelphia: Churchill Livingstone, 2005; pp 1950 - 1981.
7. Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat 1999; 6: 35-47.
8. Pawlotsky JM, Chevaliez S: Hepatitis C serologic and virologic tests and clinical diagnosis of HCV-related liver disease. Int J Med Sci 2006: 3: 35-45.
9. Zer Y, Karaoglan I, Cicek H, et al: Evaluation of the patients with low levels of anti-HCV positivity. Mikrobiyol Bul 2009; 43: 133-139 [in Turkish].
10. Baath L, Widel A, Nordenfelt E: A comparison between one first generation and three second generation anti-HCV ELISAs: an investigation in high- and low-risk subjects in correlation with recombinant immunoblot assay and polymerase chain reaction. J Virol Methods 1992; 40: 287-296.
11. Nakagiri I, Ichihara K, Ohmoto M, et al: Analysis of discordant test results among five second-generation assays for anti-hepatitis C virus antibodies also tested by polymerase chain reaction-RNA assay and other laboratory and clinical tests for hepatitis. J Clin Microbiol 1993; 31: 2974-2980. (Pubitemid 23318388)
12. Alter HJ: New kit on the block: evaluation of second-generation assay for detection of antibody to the hepatitis C virus. Hepatology 1992; 15: 350-353.
13. Colin C, Lanoir D, Touzet S, et al: Sensitivity and specificity of third-generation hepatitis C virus antibody detection assay: an analysis of the literature. J Viral Hepat 2001; 8: 87-95. (Pubitemid 32234861)
14. Quer J, Esteban J: Epidemiology. In: Viral Hepatitis, 3rd edn (Thomas HC, Lemon S, Zukerman AJ, eds). Malden: Blackwell, 2005; pp 407 - 425.
15. Delialioǧlu N, Ozturk C, Aslan G: Seroprevalence of HBsAg, anti-HBs, anti-HCV and anti-HDV in Mersin region. Viral Hepat Derg 2001; 7: 416-418 [in Turkish].
16. Aslan G, Ulukanligil M, Seyrek A: Seroprevalence of HBsAg, Anti-HBs, Anti-HCV and Anti-HDV in Şanliurfa region. Viral Hepat Derg 2001; 7: 408-410 [in Turkish].
17. Bozkurt H, Kurtoǧlu MG, Bayram Y, et al: Distribution of hepatitis C prevalence in individuals according to their age level in Eastern Turkey. Eur J Gastroenterol Hepatol 2008; 20: 1249.
18. Tekerekoǧlu MS, Akta E, Ozerol I, et al: Seropositivity of HBsAg, Anti-HCV and Anti- HIV in age group of 18 - 45. Viral Hepat Derg 2004; 9: 46-49 [in Turkish].
19. Kölgelier S, Ertek M, Erol S, et al: Seroprevalence of hepatitis C in Erzurum region. Viral Hepat Derg 2003; 8: 166-170 [in Turkish].
20. Kaygusuz S, Kiliç D, Eyaşlioǧlu E, et al: The findings of HAV, HBV and HCV seropositivity in Kirikkale according to age and sex. Viral Hepatit Derg 2003; 8: 160-165 [in Turkish].
21. Ansari MHK, Omrani MD: Evaluations of diagnostic value of ELISA method (EIA) & PCR in diagnosis of hepatitis C virus in hemodialysis patients. Hepatitis Monthly 2006; 6: 19-23.
22. Roome AJ, Hadler JL, Thomas AL, et al: Hepatitis C virus infection among firefighters, emergency medical technicians, and paramedics-selected locations, United States, 1991 - 2000. MMWR Morb Mortal Wkly Rep 2000; 49: 660-665.
23. Wu FB, Ouyan HQ, Tang XY, et al: Double-antigen sandwich time-resolved immunofluorometric assay for the detection of anti-hepatitis C virus total antibodies with improved specificity and sensitivity. J Med Microbiol 2008; 57: 1-7.
24. Karsligil T, Belgin T, Balci I, et al: Comparison of ELISA, RIBA and b-DNA in HCV infection. Viral Hepat Derg 2001; 7: 393-396 [in Turkish].
25. Tobler LH, Lee SR, Stramer SL, et al: Performance of second and third-generation RIBAs for confirmation of third-generation HCV-reactive blood donations. Transfusion 2000; 40: 917-923.
26. Kaşifoglu N, Us T, Akgün Y: Comparison of hepatitis C virus (HCV) RNA and anti-HCV results and evaluation of the relationship between transaminase levels. Mikrobiyol Bul 2007; 41: 557-563 [in Turkish].
27. Schröter M, Feucht HH, Schafer P, et al: Definition of false-positive reactions in screening for hepatitis C virus antibodies. J Clin Microbiol 1999; 37: 233-234. (Pubitemid 29004216)
28. Chevaliez S, Pawlotsky JM: Hepatitis C virus serologic and virologic tests and clinical diagnosis of HCV-related liver disease. Int J Med Sci 2006; 3: 35-40.
29. Centers for Disease Control and Prevention: Recommendations for the prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR Recomm Rep 1998; 47(RR-19): 1-39.
30. Gonçales NS, Costa FF, Vassallo J, et al: Diagnosis of hepatitis C virus in Brazilian blood donors using a reverse transcriptase nested polymerase chain reaction: comparison with enzyme immunoassay and recombinant protein immunoblot assay. Rev Inst Med Trop Sao Paulo 2000; 42: 263-267.
31. Dufor DR, Talastas M, Fernandez MDA, et al: An important predictor factor of low likelihood of hepatitis C infection. Clin Chem 2003; 49: 479-486.